Skip to main content
. 2021 Sep 20;8:728496. doi: 10.3389/fmed.2021.728496

Figure 4.

Figure 4

Clinical translation of MSC therapies in kidney disease. Illustrative representation of the diversification of MSC-based products in clinical trials of kidney transplantation, acute kidney injury, chronic kidney disease, diabetic nephropathy and lupus nephritis, including cell source and donor origin, and clinical variables, such as delivery route and clinical phase in.